Role of PI3K, MAPK/ERK 1/2, and p38 in Production of Erythropoietic Activity by Bone Marrow Cells after Blood Loss
- Authors: Zhdanov V.V.1, Miroshnichenko L.A.1, Udut E.V.1, Zyuz’kov G.N.1, Khrichkova T.Y.1, Simanina E.V.1, Sherstoboev E.Y.1, Stavrova L.A.1, Agafonov V.I.1, Chaikovskii A.V.1, Minakova M.Y.1, Dygai A.M.1
-
Affiliations:
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
- Issue: Vol 162, No 1 (2016)
- Pages: 51-55
- Section: Pharmacology and Toxicology
- URL: https://journals.rcsi.science/0007-4888/article/view/237898
- DOI: https://doi.org/10.1007/s10517-016-3543-7
- ID: 237898
Cite item
Abstract
The leading role in the regulation of erythropoietic activity of adherent bone marrow cells under conditions of post-hemorrhagic anemia is played by classical MAP kinase pathway (ERK pathway). Erythropoietin is not the decisive factor in the formation of erythropoietic activity of adherent cells. PI3K, MAPK/ERK 1/2, and p38-signaling proteins are not the main regulators of local production of erythropoietin after 30% loss of circulating blood volume.
About the authors
V. V. Zhdanov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
L. A. Miroshnichenko
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Author for correspondence.
Email: laarmi@yandex.ru
Russian Federation, Tomsk
E. V. Udut
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
G. N. Zyuz’kov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
T. Yu. Khrichkova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
E. V. Simanina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
E. Yu. Sherstoboev
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
L. A. Stavrova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
V. I. Agafonov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
A. V. Chaikovskii
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
M. Yu. Minakova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk
A. M. Dygai
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine
Email: laarmi@yandex.ru
Russian Federation, Tomsk